Clin2
NCT06676800Possibly a fitNot yet recruiting

Yiqi Gubiao pill for COPD with active tuberculosis

Tuberculosis-related Obstructive Pulmonary Disease

Part of Infections, Lungs & breathing clinical trials.

This study tests whether a traditional Chinese medicine pill, Yiqi Gubiao, can help people who have both COPD and active tuberculosis. The goal is to see if it improves breathing and overall health without interfering with standard TB treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
74 people
Ages
40 years to 75 years
Study type
Interventional

Who can take part

  • You are between 40 and 75 years old.
  • You have been diagnosed with active tuberculosis (TB) and also have COPD.
  • You have not taken steroids, TB medications, or other immune-suppressing drugs in the past month.
  • You are willing to participate and sign a consent form.
  • You do not have other serious lung conditions like a collapsed lung, fluid in the lungs, or lung cancer.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06403943Recruiting· Phase 4
Chinese herbs with standard TB treatment for lung health

This trial tests if adding a Chinese herbal formula (BaiDiZiYin ShenQiYiFei) to standard tuberculosis drugs helps improve symptoms like shortness of breath, fatigue, and coughing. It may be helpful for people diagnosed with pulmonary TB who also have signs of Qi and Yin deficiency (a traditional Chinese medicine pattern).

Beijing, Beijing Municipality
NCT07114120Recruiting· Phase 4
Bailing capsules and Guben Kechuan granules for stable bronchiectasis

This trial tests whether two Chinese herbal medicines, Bailing capsules and Guben Kechuan granules, can help people with stable bronchiectasis. It aims to reduce flare-ups and improve lung function.

Hangzhou, Zhejiang
NCT06375824Not yet recruiting
Traditional Chinese medicine to help prevent COPD in people at risk

This study tests a traditional Chinese herbal recipe (Bufei) to see if it can reduce the number of people who develop chronic obstructive pulmonary disease (COPD). It is for people who have a history of chronic cough, phlegm, or shortness of breath and certain risk factors like smoking.

NCT07131020Recruiting
Moxibustion for immune function in stable COPD

This study tests whether a type of moxibustion (a traditional Chinese heat therapy) called Yifei Moxibustion can help improve immune function in people with stable COPD. Researchers will look at tiny particles in your blood called exosomes to understand how the treatment works.

Zhengzhou, Henan
NCT07178184Not yet recruiting· Phase 2
Herbal treatment for pneumoconiosis

This study tests a modified traditional Chinese herbal formula (Qing-Zao-Jiu-Fei Decoction) to see if it helps people with pneumoconiosis (a chronic lung disease caused by dust exposure). The treatment aims to reduce symptoms and improve lung health.

NCT07456813Not yet recruiting
Herbal granules to help recovery after a COPD flare-up

This study tests whether an herbal medicine called Guben Kechuan granules can help you recover more fully after a COPD flare-up. It aims to support your immune system and reduce inflammation, which may help you feel better as you leave the hospital.

Hear when a new Tuberculosis-related Obstructive Pulmonary Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.